First Trust Advisors LP Axogen, Inc. Transaction History

First Trust Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$14.62 - $22.13 $378,058 - $572,259	-25,859 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$17.09 - $38.25 $1.42 Million - $3.19 Million	-83,283 Reduced 76.31%	25,859 $528,000
Q3 2018 Oct 25, 2018	BUY	$34.05 - $55.9 $88,053 - $144,557	2,586 Added 2.43%	109,142 $4.02 Million
Q2 2018 Aug 02, 2018	BUY	$36.15 - $52.5 $3.85 Million - $5.59 Million	106,556 New	106,556 $5.35 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.